These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 28751776)
21. The aryl hydrocarbon receptor modulates the function of human CD56 Moreno-Nieves UY; Mundy DC; Shin JH; Tam K; Sunwoo JB Eur J Immunol; 2018 May; 48(5):771-776. PubMed ID: 29336030 [TBL] [Abstract][Full Text] [Related]
22. Participation of the CD94 receptor complex in costimulation of human natural killer cells. Voss SD; Daley J; Ritz J; Robertson MJ J Immunol; 1998 Feb; 160(4):1618-26. PubMed ID: 9469418 [TBL] [Abstract][Full Text] [Related]
23. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416 [TBL] [Abstract][Full Text] [Related]
24. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis. Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273 [TBL] [Abstract][Full Text] [Related]
25. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype. Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D Virol J; 2016 Apr; 13():67. PubMed ID: 27091211 [TBL] [Abstract][Full Text] [Related]
26. The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset. Chieregato K; Zanon C; Castegnaro S; Bernardi M; Amati E; Sella S; Rodeghiero F; Astori G Blood Transfus; 2017 Jan; 15(1):93-100. PubMed ID: 27136441 [TBL] [Abstract][Full Text] [Related]
27. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion. Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331 [TBL] [Abstract][Full Text] [Related]
28. An early increase of CD56 Iniesta P; Revilla N; Chen-Liang TH; Hurtado AM; Vicente V; Heras I; Jerez A; Lozano ML Transfusion; 2018 Dec; 58(12):2924-2932. PubMed ID: 30260547 [TBL] [Abstract][Full Text] [Related]
29. Invasive Surgery Impairs the Regulatory Function of Human CD56 bright Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis. Reinhardt R; Pohlmann S; Kleinertz H; Hepner-Schefczyk M; Paul A; Flohé SB PLoS One; 2015; 10(6):e0130155. PubMed ID: 26090673 [TBL] [Abstract][Full Text] [Related]
30. CD300c is uniquely expressed on CD56 bright Natural Killer Cells and differs from CD300a upon ligand recognition. Dimitrova M; Zenarruzabeitia O; Borrego F; Simhadri VR Sci Rep; 2016 Apr; 6():23942. PubMed ID: 27040328 [TBL] [Abstract][Full Text] [Related]
31. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. Marquardt N; Béziat V; Nyström S; Hengst J; Ivarsson MA; Kekäläinen E; Johansson H; Mjösberg J; Westgren M; Lankisch TO; Wedemeyer H; Ellis EC; Ljunggren HG; Michaëlsson J; Björkström NK J Immunol; 2015 Mar; 194(6):2467-71. PubMed ID: 25672754 [TBL] [Abstract][Full Text] [Related]
32. Human Hepatic CD56 Jameson G; Harmon C; Santiago RM; Houlihan DD; Gallagher TK; Lynch L; Robinson MW; O'Farrelly C Front Immunol; 2022; 13():921212. PubMed ID: 35865550 [TBL] [Abstract][Full Text] [Related]
33. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection. Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430 [TBL] [Abstract][Full Text] [Related]
34. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans. Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023 [TBL] [Abstract][Full Text] [Related]
35. Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor Blockade. Mehling M; Burgener AV; Brinkmann V; Bantug GR; Dimeloe S; Hoenger G; Kappos L; Hess C Scand J Immunol; 2015 Nov; 82(5):460-6. PubMed ID: 26285786 [TBL] [Abstract][Full Text] [Related]
36. CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. Carrega P; Bonaccorsi I; Di Carlo E; Morandi B; Paul P; Rizzello V; Cipollone G; Navarra G; Mingari MC; Moretta L; Ferlazzo G J Immunol; 2014 Apr; 192(8):3805-15. PubMed ID: 24646734 [TBL] [Abstract][Full Text] [Related]
37. Peripheral blood CD56(bright) NK cells respond to stem cell factor and adhere to its membrane-bound form after upregulation of c-kit. Pradier A; Tabone-Eglinger S; Huber V; Bosshard C; Rigal E; Wehrle-Haller B; Roosnek E Eur J Immunol; 2014 Feb; 44(2):511-20. PubMed ID: 24150691 [TBL] [Abstract][Full Text] [Related]
38. Blimp-1 homolog Hobit identifies effector-type lymphocytes in humans. Vieira Braga FA; Hertoghs KM; Kragten NA; Doody GM; Barnes NA; Remmerswaal EB; Hsiao CC; Moerland PD; Wouters D; Derks IA; van Stijn A; Demkes M; Hamann J; Eldering E; Nolte MA; Tooze RM; ten Berge IJ; van Gisbergen KP; van Lier RA Eur J Immunol; 2015 Oct; 45(10):2945-58. PubMed ID: 26179882 [TBL] [Abstract][Full Text] [Related]
39. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Vitale M; Della Chiesa M; Carlomagno S; Romagnani C; Thiel A; Moretta L; Moretta A Eur J Immunol; 2004 Jun; 34(6):1715-22. PubMed ID: 15162442 [TBL] [Abstract][Full Text] [Related]
40. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients. Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]